20/20 BIOLABS, INC. Operating Lease Right-of-Use Assets
20/20 BIOLABS, INC. (AIDX) had Operating Lease Right-of-Use Assets of $519.30 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-14
- 2026-06-30: Operating Lease, Right-of-Use Asset $519.30K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $562.51K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $605.29K.
- 2024-12-31: Operating Lease, Right-of-Use Asset $772.38K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $519.30K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $562.51K 10-Q · filed 2026-05-20 |
| 2025-12-31 | $605.29K 10-Q · filed 2026-08-14 |
| 2024-12-31 | $772.38K POS AM · filed 2026-04-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGENOMICS INC (NEO) | United States | $2.514B | -35.96 |